The ADAM9-CDCP1 axis was confirmed to be necessary for lung cancer cell migration and survival in vitro and in vivo; and moreover, the authors demonstrated that ADAM9 decreases the expression of miR-1 and miR-218, which target the 3′-UTR of CDCP1 to suppress its expression. Here, CDCP1 is linked to lung cancer.